"Wasting Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition of involuntary weight loss of greater then 10% of baseline body weight. It is characterized by atrophy of muscles and depletion of lean body mass. Wasting is a sign of MALNUTRITION as a result of inadequate dietary intake, malabsorption, or hypermetabolism.
| Descriptor ID |
D019282
|
| MeSH Number(s) |
C18.452.915 C18.654.940
|
| Concept/Terms |
Wasting Syndrome- Wasting Syndrome
- Wasting Syndromes
- Wasting Disease
- Wasting Diseases
|
Below are MeSH descriptors whose meaning is more general than "Wasting Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Wasting Syndrome".
This graph shows the total number of publications written about "Wasting Syndrome" by people in this website by year, and whether "Wasting Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Wasting Syndrome" by people in Profiles.
-
Diets for patients with chronic kidney disease, should we reconsider? BMC Nephrol. 2016 07 11; 17(1):80.
-
Adverse Effects of Sporadic Dialysis on Body Composition. Nephron. 2015; 131(1):73-7.
-
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013 Mar; 23(2):77-90.
-
Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin. Clin Exp Nephrol. 2013 Apr; 17(2):174-82.
-
IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol. 2009 Mar; 20(3):604-12.
-
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008 Feb; 73(4):391-8.
-
Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein. Mol Hum Reprod. 2007 Sep; 13(9):675-83.
-
SMAD3 regulates gonadal tumorigenesis. Mol Endocrinol. 2007 Oct; 21(10):2472-86.
-
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest. 2005 Feb; 115(2):451-8.
-
Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice. Mol Endocrinol. 2004 Jun; 18(6):1509-19.